Prediction of the permeability of antineoplastic agents through nitrile medical gloves by zone classification based on their physicochemical properties.
Antineoplastic agents
Medical gloves
Molecular weight
Nitrile
Permeability
Physicochemical properties
Zone classification
Journal
Journal of pharmaceutical health care and sciences
ISSN: 2055-0294
Titre abrégé: J Pharm Health Care Sci
Pays: England
ID NLM: 101672177
Informations de publication
Date de publication:
02 Nov 2020
02 Nov 2020
Historique:
received:
22
07
2020
accepted:
29
09
2020
entrez:
9
12
2020
pubmed:
10
12
2020
medline:
10
12
2020
Statut:
epublish
Résumé
Permeability of antineoplastic agents through medical gloves is an important factor that must be considered for the appropriate selection of gloves. However, predicting the permeability of antineoplastic agents through medical gloves based on their physicochemical properties remains difficult. Thus, this study aimed to elucidate the relationship between the physicochemical properties and permeability of antineoplastic agents through medical gloves. Additionally, we tried to predict the risk of permeation of antineoplastic agents through medical gloves based on physicochemical parameters. Ten antineoplastic agents (carboplatin, carmustine, cisplatin, cyclophosphamide, doxorubicin, etoposide, fluorouracil, ifosfamide, oxaliplatin, and paclitaxel) with varying physicochemical properties were investigated, and their permeation rates (PRs) through nitrile medical gloves of varying thicknesses (0.05, 0.07, and 0.1 mm) were measured using a continuous flow in-line cell device. We also determined the apparent permeation clearance (CL The CL The permeation risk of antineoplastic agents through nitrile medical gloves within the actual continuous wearing time in clinical settings could be predicted using MW and LogP values. We believe that the proposed zone classification of antineoplastic agents will be a useful tool for predicting the permeation risk of antineoplastic agents through medical gloves.
Sections du résumé
BACKGROUND
BACKGROUND
Permeability of antineoplastic agents through medical gloves is an important factor that must be considered for the appropriate selection of gloves. However, predicting the permeability of antineoplastic agents through medical gloves based on their physicochemical properties remains difficult. Thus, this study aimed to elucidate the relationship between the physicochemical properties and permeability of antineoplastic agents through medical gloves. Additionally, we tried to predict the risk of permeation of antineoplastic agents through medical gloves based on physicochemical parameters.
METHODS
METHODS
Ten antineoplastic agents (carboplatin, carmustine, cisplatin, cyclophosphamide, doxorubicin, etoposide, fluorouracil, ifosfamide, oxaliplatin, and paclitaxel) with varying physicochemical properties were investigated, and their permeation rates (PRs) through nitrile medical gloves of varying thicknesses (0.05, 0.07, and 0.1 mm) were measured using a continuous flow in-line cell device. We also determined the apparent permeation clearance (CL
RESULTS
RESULTS
The CL
CONCLUSIONS
CONCLUSIONS
The permeation risk of antineoplastic agents through nitrile medical gloves within the actual continuous wearing time in clinical settings could be predicted using MW and LogP values. We believe that the proposed zone classification of antineoplastic agents will be a useful tool for predicting the permeation risk of antineoplastic agents through medical gloves.
Identifiants
pubmed: 33292621
doi: 10.1186/s40780-020-00179-3
pii: 10.1186/s40780-020-00179-3
pmc: PMC7604926
doi:
Types de publication
Journal Article
Langues
eng
Pagination
23Références
Scand J Work Environ Health. 1980 Dec;6(4):299-301
pubmed: 7233118
J Occup Environ Hyg. 2020 Apr;17(4):172-180
pubmed: 32091311
J Pharm Health Care Sci. 2017 May 2;3:13
pubmed: 28469932
Mutat Res. 1999 Feb 2;439(1):97-104
pubmed: 10029685
Cancer Invest. 1986;4(2):127-35
pubmed: 3518876
Am J Health Syst Pharm. 2003 May 15;60(10):1006-11
pubmed: 12789871
J Occup Health. 2008;50(1):7-12
pubmed: 18285639
Am J Health Syst Pharm. 2014 Jan 15;71(2):145-66
pubmed: 24375608
Am J Health Syst Pharm. 2018 Dec 15;75(24):1996-2031
pubmed: 30327293
Mutat Res. 1985 Sep;154(2):135-49
pubmed: 3929080
Am J Health Syst Pharm. 2006 Mar 15;63(6):547-56
pubmed: 16522891